Ownership
Private
Therapeutic Areas
Other
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
DeviceReagent (for research use; not therapeutic)

Azure Biosystems General Information

Azure Biosystems develops and commercializes advanced imaging instruments and reagents used in life science research. Their products are widely adopted in academic and industrial labs globally for applications such as Western blotting, gel documentation, nucleic acid/protein quantification, real-time PCR analysis, ELISA assays, and more. The company does not develop therapeutics or diagnostics but enables scientific discovery through high-performance laboratory tools.

Contact Information

Primary Industry
Non-Drug Biotech
Corporate Office
Dublin, California
United States

Drug Pipeline

No pipeline data available

For full access to Azure Biosystems's pipeline data

Book a demo

Key Partnerships

Distributors such as Cambridge Bioscience in the UK

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Azure Biosystems Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Azure Biosystems's complete valuation and funding history, request access »

Azure Biosystems Financial Metrics